Unlike Ruan et al. (2018), which quantitatively assessed the extent of p16INK4a methylation, potentially identifying thresholds or patterns relevant to ovarian cancer, Jiang et al. (2017) only tested the association [74,75,76] between p16INK4a methylation and ovarian carcinoma. Here, CDKN2A is linked to ovarian cancer.